PATENTS LICENSED FROM VEILED THERAPEUTICS, LLC
US
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation
Prov. Appl. No. 61/877,521-Filed September 13, 2013
Australia
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation
Appl. No. 2014318471
Canada
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation
Appl. No. 2,922,002
China
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation
Appl. No. 201480062013X
Filed May 12, 2016
Europe
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation
Appl. No. 14780682.2
India
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation
Appl. No. 201647012079
Japan
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation
Appl. No. 2016-542842
Filed March 11, 2016
Korea
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation
Appl. No. 2016-7009662
Mexico
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation
Appl. No. MX/a/2016/003265
New Zealand
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation
Appl. No. 717103
PCT
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation
App. No. PCT/US2014/055539
Singapore
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation
Appl. No. 11201601311V
US
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation
Patent No. 9,468,603
US Continuation 1
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation
Appl. No. 15910913
Filed March 2, 2018
US
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation
Granted Dec. 1, 2017
Australia
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
Patent No. 2012275953
Canada
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
Patent No. 2,836,914
China
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
Patent No. ZL 2012800280815
Europe
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
Appl. No. 12804651.3
India
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
Appl. No. 10374/CHENP/2013
Japan
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
Patent No. 5621071
S. Korea
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
Patent No. 1444693
Mexico
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
Patent No. 337464
New Zealand
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
Patent No. 618596
Singapore
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
Patent No. 195018
Vietnam
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
Patent No. 16328
Vietnam (Divisional)
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
Appl. No. 1-2014-01570
Patent No. 17042
US
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
Patent No. 8,440,714
US Continuation 1
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
Patent No. 8,716,328
US Continuation 2
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
Patent No. 9,339,555
US Continuation 3
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
Patent No. 9,889,201
US Continuation 4
Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
Appl. No. 15/675,399